Kyoko Ohno-Matsui Selected Research

Traction

1/2024	Characteristics and Prevalence of Staphyloma Edges at Different Ages in Highly Myopic Eyes.
11/2022	An evidence-based review of the epidemiology of myopic traction maculopathy.
10/2022	EXTREME MACULAR SCHISIS-SIMULATING RETINAL DETACHMENT IN EYES WITH PATHOLOGIC MYOPIA.
5/2022	Validation of Soft Labels in Developing Deep Learning Algorithms for Detecting Lesions of Myopic Maculopathy From Optical Coherence Tomographic Images.
9/2021	CORRELATION BETWEEN ATROPHY-TRACTION-NEOVASCULARIZATION GRADE FOR MYOPIC MACULOPATHY AND CLINICAL SEVERITY.
3/2021	Prevalence, risk factors and impact of posterior staphyloma diagnosed from wide-field optical coherence tomography in Singapore adults with high myopia.
1/2021	Characteristics of myopic traction maculopathy in myopic Singaporean adults.
1/2021	IMI Pathologic Myopia.
11/2020	VALIDATION OF THE RECENTLY DEVELOPED ATN CLASSIFICATION AND GRADING SYSTEM FOR MYOPIC MACULOPATHY.
10/2020	DEVELOPMENT OF MACULAR ATROPHY AFTER PARS PLANA VITRECTOMY FOR MYOPIC TRACTION MACULOPATHY AND MACULAR HOLE RETINAL DETACHMENT IN PATHOLOGIC MYOPIA.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kyoko Ohno-Matsui Research Topics

Disease

50	Myopia 01/2024 - 04/2004
26	Macular Degeneration (Age-Related Maculopathy) 01/2024 - 10/2005
23	Choroidal Neovascularization 08/2019 - 04/2003
22	Atrophy 01/2024 - 04/2004
13	Inflammation (Inflammations) 04/2024 - 07/2008
10	Retinal Detachment (Retinal Detachments) 01/2024 - 02/2002
10	Retinoschisis (Retinoschisis, Juvenile) 01/2024 - 09/2006
8	Uveitis 04/2024 - 01/2016
8	Glaucoma 03/2024 - 01/2015
6	Retinal Perforations 01/2024 - 03/2003
6	Neoplasms (Cancer) 01/2024 - 06/2003
5	Infections 04/2024 - 01/2020
5	Refractive Errors (Refractive Error) 01/2022 - 08/2013
4	Hemorrhage 09/2020 - 06/2013
3	Macular Edema 01/2024 - 07/2022
3	Degenerative Myopia 12/2023 - 12/2006
3	Vision Disorders (Hemeralopia) 03/2023 - 08/2010
3	Scleritis (Episcleritis) 01/2023 - 08/2018
3	Cataract (Cataracts) 11/2022 - 07/2006
3	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2022 - 03/2014
3	Cysts 01/2021 - 05/2006
3	Retinal Hemorrhage 09/2020 - 01/2003
3	Vitreous Detachment (Posterior Vitreous Detachment) 10/2015 - 05/2013
2	Hypersensitivity (Allergy) 04/2024 - 01/2021
2	Optic Neuritis (Retrobulbar Neuritis) 04/2024 - 06/2020
2	Retinitis 04/2024 - 01/2023
2	Retinal Vasculitis 01/2024 - 07/2021
2	Open-Angle Glaucoma (Glaucoma, Open Angle) 12/2023 - 06/2023
2	Polypoidal Choroidal Vasculopathy 11/2022 - 11/2008
2	Retinal Diseases 01/2022 - 12/2003
2	Cicatrix (Scar) 01/2022 - 02/2002
2	Vasculitis (Vasculitides) 10/2020 - 06/2020
2	Amyloid Plaque 07/2011 - 07/2009
1	COVID-19 02/2024
1	Posterior Uveitis 10/2023
1	Rubella (German Measles) 10/2023
1	Mumps 10/2023
1	Measles 10/2023
1	Stargardt Disease 03/2023
1	Choroidal Effusions 01/2023

Drug/Important Bio-Agent (IBA)

31	Retinaldehyde (Retinal)IBA 01/2024 - 02/2002
11	Fluorescein (Funduscein)FDA LinkGeneric 01/2024 - 02/2002
11	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2023 - 02/2002
6	1-phenyl-3,3-dimethyltriazene (PDT)IBA 11/2022 - 10/2006
5	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2022 - 05/2002
5	Ranibizumab (Lucentis)FDA Link 07/2019 - 03/2014
5	Bevacizumab (Avastin)FDA Link 06/2017 - 05/2009
4	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2016
4	Verteporfin (Visudyne)FDA Link 11/2022 - 03/2008
4	Atropine FDA LinkGeneric 01/2021 - 11/2015
4	Amyloid beta-PeptidesIBA 07/2011 - 10/2005
3	VaccinesIBA 04/2024 - 10/2023
3	Mydriatics (Cycloplegics)IBA 01/2024 - 09/2018
3	Infliximab (Remicade)FDA Link 12/2020 - 01/2016
3	SteroidsIBA 01/2020 - 08/2018
3	Indicators and Reagents (Reagents)IBA 11/2018 - 01/2006
3	Proteins (Proteins, Gene)FDA Link 12/2013 - 02/2002
3	pigment epithelium-derived factorIBA 06/2013 - 04/2003
3	Amyloid (Amyloid Fibrils)IBA 08/2012 - 07/2011
2	K-115IBA 03/2024 - 12/2023
2	Messenger RNA (mRNA)IBA 02/2024 - 02/2002
2	Antiviral Agents (Antivirals)IBA 10/2023 - 01/2023
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2023 - 07/2021
2	Therapeutic UsesIBA 01/2023 - 09/2018
2	Ophthalmic Solutions (Eye Drops)IBA 01/2021 - 01/2019
2	Colchicine FDA LinkGeneric 12/2020 - 01/2016
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2020 - 01/2016
2	Adalimumab (Humira)FDA Link 01/2020 - 01/2016
2	ResveratrolIBA 01/2020 - 01/2017
2	afliberceptIBA 08/2019 - 06/2015
2	Methotrexate (Mexate)FDA LinkGeneric 03/2019 - 09/2016
2	EnzymesIBA 08/2018 - 02/2002
2	Retinal Pigments (Pigments, Visual)IBA 07/2009 - 04/2003
1	Antigen-Antibody Complex (Immune Complex)IBA 04/2024
1	RNA (Ribonucleic Acid)IBA 04/2024
1	Attenuated VaccinesIBA 04/2024
1	COVID-19 VaccinesIBA 02/2024
1	Leukocyte Common Antigens (CD45 Antigen)IBA 01/2024
1	Prednisolone (Predate)FDA LinkGeneric 01/2024
1	Influenza Vaccines (Influenza Vaccine)FDA Link 10/2023
1	LuteinIBA 03/2023
1	Rituximab (Mabthera)FDA Link 01/2023
1	3- (2- methoxyphenyl)- 5- methoxy- 1,3,4- oxadiazol- 2(3H)- oneIBA 01/2023
1	Myeloblastin (Proteinase 3)IBA 01/2023
1	Valganciclovir FDA Link 01/2023

Therapy/Procedure

18	Traction 01/2024 - 02/2002
13	Therapeutics 01/2023 - 02/2010
9	Photochemotherapy (Photodynamic Therapy) 03/2015 - 10/2006
6	Vitrectomy 10/2020 - 01/2003
5	Lasers (Laser) 08/2021 - 04/2004
4	Intravitreal Injections 01/2020 - 05/2009
2	Contact Lenses 01/2021 - 07/2004
2	Vitreoretinal Surgery 01/2021 - 01/2016
2	Drug Therapy (Chemotherapy) 03/2019 - 09/2016
2	Light Coagulation 08/2018 - 01/2017
2	Phacoemulsification 08/2013 - 07/2006
2	Intraocular Lens Implantation 08/2013 - 07/2006
1	Solid-State Lasers 01/2024
1	Highly Active Antiretroviral Therapy (HAART) 12/2023
1	Trabeculectomy (Trabeculoplasty) 06/2023